CD19+/CD38hi/CD24hi/CXCR4+/IL-10+ cell percentages were akin in HD and ELTGF patients; however, the latter two groups had ≅32% and ≅27% higher levels versus CGD patients (P ≤ 0.03; Figure 3(q), Table 2). The gene discussed is CD19; the disease is Huntington disease.